PATENT CLAIM ANALYSIS

Application Number: 16108879
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "250000"]

Abstract:
Methods for treating a subject infected with  Clostridium difficile  comprises administering to the subject a synergistic combination of clofazimine and metronidazole. Pharmaceutical compositions comprising clofazimine and metronidazole are provided for treating  Clostridium difficile  infection and diseases or symptoms associated therewith.

Claim (Index 1):
A method of inhibiting the activity of  Clostridium difficile  in a subject, comprising administering to the subject a pharmaceutical composition consisting of a clofazimine analogue selected from the group consisting of B4154 analogue, B4129 analogue, B4087 analogue, B4165 analogue, B826 analogue, B3640 analogue, B4100 analogue, B4101 analogue, B4021 analogue, B4157 analogue, B746 analogue, and B3987 analogue; and at least one pharmaceutically acceptable excipient.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 96.0
- Lexical Diversity: 1.35484
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15421982', '15831237', '15576220', '15363523', '14888289']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7578777745919891
- 35 USC 102 Novelty (BERT): 0.640766148783007
- Combined Prediction Score: 0.746166612011091
- Mean Citation Score: 347.448196
- Max Citation Score: 643.03735
- Similarity Product: 557.8850387651354

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test